Germany is now offering a groundbreaking procedure described as a permanent cure for Type 2 diabetes. While the same treatment costs $40,000 in the United States, international patients can access it for free through select medical programs.

The therapy, called duodenal mucosal resurfacing (DMR), is a minimally invasive procedure that targets insulin resistance, the root cause of Type 2 diabetes. Using advanced endoscopic tools, DMR modifies the lining of the upper intestine, “resetting” hormonal signals that regulate glucose. Patients often experience significant improvements in blood sugar levels and insulin sensitivity, with many able to stop diabetes medication entirely. Clinical trials show some individuals maintain normal glucose levels for years after a single treatment.

Through public hospitals and global health partnerships, Germany offers this life-changing therapy to non-citizens as part of pilot programs, highlighting disparities in global healthcare access. This innovative approach may mark a turning point in reversing Type 2 diabetes worldwide.